Pricing Log in Create free account

Atea Pharmaceuticals, Inc. (AVIR) vs Turn Therapeutics Inc. (TTRX)

Atea Pharmaceuticals, Inc. and Turn Therapeutics Inc. are both Biotechnology companies. Atea Pharmaceuticals, Inc. and Turn Therapeutics Inc. are of similar size ($363.3M and $345.3M). Across the 9 metrics below, Atea Pharmaceuticals, Inc. leads on 6 and Turn Therapeutics Inc. on 3.

Valuation

Metric AVIR TTRX Biotechnology median
P/E n/m n/m 8.50
P/S 0.98 n/m 9.71
P/B 1.69 458.38 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.36 n/m 9.21
Earnings yield (48.15%) (2.74%) (33.15%)
Free cash flow yield (159.02%) (1.42%) (25.50%)

Profitability

Metric AVIR TTRX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.14%) (3,315.33%) (56.36%)
Return on assets (52.99%) (99.59%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVIR TTRX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 3.00% (80.72%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AVIR TTRX Biotechnology median
Debt to equity 0.00 8.83 0.00
Current ratio 8.13 1.19 4.72
Net debt to EBITDA 1.63 0.96 0.96

Dividend

Metric AVIR TTRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AVIR TTRX Biotechnology median
Market cap 363.33m 345.25m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack